A Safety and Tolerability Study of SCH 721015 in Patients With Transitional Cell Carcinoma of the Bladder (Study P03816)

NCT00536588 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Bladder Neoplasms

Interventions

GENETIC: SCH 721015 with SCH 209702

Sponsor

Merck Sharp & Dohme LLC